Header Logo

Caroline Alper

Concepts (59)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
6
2026
379
0.430
 Why?
Glucagon-Like Peptide 1
1
2026
26
0.240
 Why?
Overweight
1
2026
255
0.200
 Why?
Pharmacies
1
2021
36
0.170
 Why?
Pharmaceutical Services
1
2021
33
0.170
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Benzodioxoles
1
2019
15
0.150
 Why?
Aminopyridines
1
2019
36
0.150
 Why?
Quinolones
1
2019
30
0.150
 Why?
Drug Combinations
4
2022
171
0.150
 Why?
Uridine Monophosphate
1
2018
9
0.140
 Why?
Fluorenes
1
2018
15
0.140
 Why?
Cystic Fibrosis
1
2019
127
0.140
 Why?
Benzimidazoles
1
2018
57
0.140
 Why?
Obesity
1
2026
1269
0.130
 Why?
Hydrocodone
1
2017
7
0.130
 Why?
Hepatitis C, Chronic
1
2018
91
0.130
 Why?
Drug and Narcotic Control
1
2017
29
0.130
 Why?
Hepacivirus
1
2018
139
0.130
 Why?
Antiviral Agents
1
2018
330
0.110
 Why?
Lung
1
2019
972
0.110
 Why?
Heart Failure
1
2022
943
0.100
 Why?
Retrospective Studies
5
2026
6880
0.090
 Why?
Analgesics, Opioid
1
2017
537
0.090
 Why?
Practice Patterns, Physicians'
1
2017
716
0.090
 Why?
United States
5
2026
8131
0.080
 Why?
Gastric Inhibitory Polypeptide
1
2026
4
0.060
 Why?
Glucagon-Like Peptides
1
2026
4
0.060
 Why?
Anti-Obesity Agents
1
2026
16
0.060
 Why?
Adult
4
2026
17411
0.050
 Why?
Middle Aged
4
2026
18262
0.050
 Why?
Aminobutyrates
1
2022
9
0.050
 Why?
Valsartan
1
2022
12
0.050
 Why?
Tetrazoles
1
2022
22
0.050
 Why?
Biphenyl Compounds
1
2022
33
0.050
 Why?
Angiotensin Receptor Antagonists
1
2022
65
0.040
 Why?
Cost-Benefit Analysis
1
2022
320
0.040
 Why?
Stroke Volume
1
2022
338
0.040
 Why?
Massachusetts
1
2026
2149
0.040
 Why?
Humans
6
2026
65536
0.040
 Why?
Male
4
2026
31067
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
80
0.040
 Why?
Female
4
2026
34115
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Ribavirin
1
2018
23
0.040
 Why?
Sofosbuvir
1
2018
19
0.040
 Why?
Young Adult
2
2019
4832
0.030
 Why?
Treatment Failure
1
2018
208
0.030
 Why?
Controlled Substances
1
2017
5
0.030
 Why?
Viral Load
1
2018
228
0.030
 Why?
Adolescent
2
2019
6378
0.030
 Why?
RNA, Viral
1
2018
272
0.030
 Why?
Drug Therapy, Combination
1
2018
473
0.030
 Why?
Genotype
1
2018
679
0.030
 Why?
Treatment Outcome
1
2026
5818
0.030
 Why?
Mutation
1
2019
2680
0.020
 Why?
Child
1
2019
4681
0.020
 Why?
Aged
1
2018
14942
0.010
 Why?
Alper's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_